

Generic drugmaker Actavis Inc.'s plan to take over Dublin, Ireland-based Warner Chilcott plc in a stock-for-stock transaction worth about $8.5 billion, thus forming the world's third-largest specialty pharmaceutical firm, would put the combined firm – with about $11 billion in annual revenues – on even more solid footing in the busily consolidating biosimilars realm. more »

As sales of Incyte Corp.'s approved JAK inhibitor Jakafi (ruxolitinib) begin to pick up steam, a competing myelofibrosis candidate from Sanofi SA moved a step closer to market. more »

Last week, researchers from Oregon Health & Science University reported that they had created embryonic stem cells via somatic cell nuclear transfer (SCNT), with a high enough efficiency to bring the creation of patient-specific embryonic stem cell lines into the realm of the possible.
Major depression affects more than 15 percent of the population at some point in their lives, and about 7 percent in any given year. Currently approved antidepressants are effective only about half the time and even then, with a lag time of several weeks after a patient starts taking them.
READ MORE »- Sepsis Patients May Need Bigger Immune Response »
- No Working Kinase, but ErbB3 Acquires Oncogenic Mutations »
- Fungal Protein Points Way to New Breast Cancer Treatments »
- Short-lived Stem Cells Fight Brain Tumors, for a Time »
- Exhausted T Cells Can Rally Given Right Circumstances »
- Study Highlights New Target for Antidepressant Therapy »
- Adult Neurons Can Learn New Neurotransmitter 'Languages' »
- Study Could Lead to Inhibitors for Multidrug Molecular Pump »
- Weakened, Radioactive Listeria Poison Metastases, Not the Gut »

- Biotech’s White Knight (aka Serial Cheater) Gets Prison Time, FinallyMay 03, 2013 | 3:41 PM | Posted by: Lynn Yoffee
- Where’s Superman When He’s Needed?April 30, 2013 | 10:07 AM | Posted by: Mari Serebrov
- Biopeople to Meet at BIO2013: Inside the World of Biotech’s Luminaries, Titans and BrainiacsApril 19, 2013 | 8:38 AM | Posted by: Lynn Yoffee
- Cancer Research Through Time: Cure Should’ve Been Wrapped up by 1985April 08, 2013 | 11:50 AM | Posted by: Anette Breindl
- ‘ImaginAb’ That! BioWorld Salutes ‘Overall Awesomeness’April 01, 2013 | 1:46 PM | Posted by: Jennifer Boggs
Cast Your Vote
Building 6, Suite 400 | Atlanta, Georgia 30305, USA
Free Ezine
Sign up for Perspectives FREE e-mail newsletter.
Outside the U.S.: 1-404-262-5423
customerservice@bioworld.com
Hours: Monday - Thursday, 8:30 am - 6:00 pm EST
Friday, 8:30am - 4:30 pm EST


